Japan Hosts $290 Million in COVID-Related Pharma Projects

KOFU, JAPAN--August 5, 2022--Researched by Industrial Info Resources (Sugar Land, Texas)--Major Japanese pharmaceutical companies are producing active pharmaceutical ingredients (API) and/or performing fill-and-finish services at plants that produce COVID-19 vaccines. Projects range from grassroot developments at contract manufacturing organization (CMO) plants, to expansions at a variety of existing plants.